Amoy Diagnostics Co., Ltd. (SHE:300685)
20.54
-1.79 (-8.02%)
Apr 28, 2026, 3:04 PM CST
Amoy Diagnostics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,066 | 828.87 | 552.79 | 494.69 | 402.88 |
Trading Asset Securities | 275.96 | 351.89 | 469.12 | 259.3 | 315.85 |
Cash & Short-Term Investments | 1,342 | 1,181 | 1,022 | 753.98 | 718.73 |
Cash Growth | 13.64% | 15.54% | 35.53% | 4.90% | 7.85% |
Accounts Receivable | 655.26 | 543.3 | 537.01 | 468.53 | 433.64 |
Other Receivables | 8.44 | 11.79 | 21.64 | 17.14 | 1.97 |
Receivables | 663.7 | 555.09 | 558.65 | 485.68 | 435.61 |
Inventory | 37.34 | 34.37 | 28.78 | 32.84 | 32.27 |
Other Current Assets | 10.07 | 18.19 | 11.13 | 12.64 | 9.41 |
Total Current Assets | 2,053 | 1,788 | 1,620 | 1,285 | 1,196 |
Property, Plant & Equipment | 179.41 | 186.25 | 193.89 | 208.27 | 209.51 |
Long-Term Investments | 50 | 11.95 | 32 | 58.61 | 67.62 |
Other Intangible Assets | 42.47 | 43.58 | 48.55 | 47.21 | 19.07 |
Long-Term Deferred Tax Assets | 12.57 | 10.06 | 5.25 | 6.53 | 20.46 |
Long-Term Deferred Charges | 5.41 | 4.74 | 6.34 | 4.88 | 1.03 |
Other Long-Term Assets | 4.83 | 19.82 | 28.38 | 40.29 | 6.17 |
Total Assets | 2,348 | 2,065 | 1,935 | 1,651 | 1,520 |
Accounts Payable | 21.95 | 19.7 | 17.9 | 21.33 | 24.02 |
Accrued Expenses | 103.72 | 64.19 | 69.99 | 52.84 | 56.55 |
Short-Term Debt | 2 | - | 5 | - | - |
Current Portion of Long-Term Debt | 3.32 | 44.45 | 2.29 | 2.29 | - |
Current Portion of Leases | 4.13 | 4.07 | 2.82 | 3.04 | 3.06 |
Current Income Taxes Payable | 19.61 | 20.27 | 17.23 | 3.37 | 0.45 |
Current Unearned Revenue | 3.79 | 4.28 | 4.34 | 4.36 | 9.08 |
Other Current Liabilities | 19.62 | 37.86 | 54.91 | 4.73 | 42.05 |
Total Current Liabilities | 178.12 | 194.82 | 174.48 | 91.97 | 135.21 |
Long-Term Debt | 94.42 | - | 44.4 | 46.64 | - |
Long-Term Leases | 4.74 | 8.73 | 2.17 | 1.66 | 3 |
Long-Term Unearned Revenue | 14.32 | 17.98 | 10.52 | 10.26 | 11.15 |
Long-Term Deferred Tax Liabilities | 0.09 | - | - | 0.66 | 0.88 |
Total Liabilities | 291.69 | 221.54 | 231.56 | 151.2 | 150.25 |
Common Stock | 391.54 | 398.44 | 398.6 | 398.16 | 221.72 |
Additional Paid-In Capital | 111.88 | 232.08 | 218.3 | 270.38 | 459.23 |
Retained Earnings | 1,576 | 1,331 | 1,136 | 929.44 | 716.47 |
Treasury Stock | -25.45 | -120.44 | -51.66 | -99.99 | -32.76 |
Comprehensive Income & Other | 2.27 | 2.14 | 2.35 | 1.74 | -0.08 |
Total Common Equity | 2,056 | 1,843 | 1,703 | 1,500 | 1,365 |
Minority Interest | - | - | - | - | 5.05 |
Shareholders' Equity | 2,056 | 1,843 | 1,703 | 1,500 | 1,370 |
Total Liabilities & Equity | 2,348 | 2,065 | 1,935 | 1,651 | 1,520 |
Total Debt | 108.6 | 57.26 | 56.68 | 53.64 | 6.06 |
Net Cash (Debt) | 1,233 | 1,124 | 965.23 | 700.34 | 712.67 |
Net Cash Growth | 9.77% | 16.40% | 37.82% | -1.73% | 6.94% |
Net Cash Per Share | 3.07 | 2.82 | 2.44 | 1.78 | 1.78 |
Filing Date Shares Outstanding | 391.13 | 393.76 | 400.21 | 398.16 | 399.1 |
Total Common Shares Outstanding | 391.13 | 393.76 | 400.21 | 398.16 | 399.1 |
Working Capital | 1,875 | 1,594 | 1,446 | 1,193 | 1,061 |
Book Value Per Share | 5.26 | 4.68 | 4.26 | 3.77 | 3.42 |
Tangible Book Value | 2,013 | 1,800 | 1,655 | 1,453 | 1,346 |
Tangible Book Value Per Share | 5.15 | 4.57 | 4.13 | 3.65 | 3.37 |
Buildings | 122.47 | 122.47 | 122.47 | 121.45 | 120.63 |
Machinery | 303.71 | 313.69 | 288.06 | 255.95 | 225.24 |
Construction In Progress | 1.81 | - | - | 2.98 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.